For the year ending 2025-12-31, HBIO made $86,550K in revenue. -$56,700K in net income. Net profit margin of -65.51%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Revenues | 86,550 | |||
| Cost of revenues | 36,640 | |||
| Gross profit | 49,910 | |||
| Sales and marketing expenses | 19,216 | |||
| General and administrative expenses | 17,742 | |||
| Research and development expenses | 8,825 | |||
| Amortization of acquired intangible assets | 4,027 | |||
| Goodwill impairment - note 5 | 47,951 | |||
| Other operating expenses - note 2 | 729 | |||
| Total operating expenses | 98,490 | |||
| Operating loss | -48,580 | |||
| Interest expense | -4,917 | |||
| Loss on pension settlement - note 8 | 1,233 | |||
| Loss on equity securities - note 12 | 0 | |||
| Other expense, net | -2,656 | |||
| Total other expense | -8,806 | |||
| Loss before income taxes | -57,386 | |||
| Income tax (benefit) expense | -686 | |||
| Net loss | -56,700 | |||
| Basic EPS | -1.28 | |||
| Diluted EPS | -1.28 | |||
| Basic Average Shares | 44,391,000 | |||
| Diluted Average Shares | 44,391,000 | |||
HARVARD BIOSCIENCE INC (HBIO)
HARVARD BIOSCIENCE INC (HBIO)